AMN Healthcare Files 8-K for Financial Results and Exhibits

TL;DR

**AMN Healthcare just filed an 8-K reporting financial results, so expect an update on their performance soon.**

AI Summary

AMN HEALTHCARE SERVICES, INC. filed an 8-K on February 15, 2024, to report on its Results of Operations and Financial Condition, along with Financial Statements and Exhibits. This filing, under Commission File Number 001-16753, indicates the company is providing an update on its financial performance, though specific financial figures are not detailed in this initial filing text. The company's principal executive offices are located in Dallas, Texas.

Why It Matters

This filing signals that AMN Healthcare is providing an update on its financial performance, which is crucial for investors to assess the company's health and future prospects. While specific details are not in this excerpt, the full filing would contain key financial metrics.

Risk Assessment

Risk Level: low — This 8-K filing is a routine disclosure of financial results and exhibits, not indicating any immediate unusual risk based on the provided text.

Key Players & Entities

• AMN HEALTHCARE SERVICES, INC. (company) — registrant
• Dallas (company) — principal executive offices city
• Texas (company) — principal executive offices state
• Delaware (company) — state of incorporation

FAQ

From the Filing

0000950142-24-000460.txt : 20240215 0000950142-24-000460.hdr.sgml : 20240215 20240215161547 ACCESSION NUMBER: 0000950142-24-000460 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240215 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240215 DATE AS OF CHANGE: 20240215 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMN HEALTHCARE SERVICES INC CENTRAL INDEX KEY: 0001142750 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HELP SUPPLY SERVICES [7363] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 061500476 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-16753 FILM NUMBER: 24644009 BUSINESS ADDRESS: STREET 1: 2999 OLYMPUS BOULEVARD STREET 2: SUITE 500 CITY: DALLAS STATE: TX ZIP: 75019 BUSINESS PHONE: 8668718519 MAIL ADDRESS: STREET 1: 2999 OLYMPUS BOULEVARD STREET 2: SUITE 500 CITY: DALLAS STATE: TX ZIP: 75019 8-K 1 eh240448596_8k.htm FORM 8-K false 0001142750 0001142750 2024-02-15 2024-02-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares       UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 15, 2024   AMN HEALTHCARE SERVICES, INC. (Exact name of registrant as specified in its charter)   Delaware 001-16753 06-1500476 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.)       2999 Olympus Boulevard , Suite 500 Dallas , Texas 75019 (Address of principal executive offices) (Zip Code)   ( 866 ) 871-8519 (Registrant’s Telephone Number, Including Area Code)   Not Applicable (Former Name or Former Address, if Changed Since Last Report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):     ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)         ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)         ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act  (17 CFR 240.14d-2(b))         ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act  (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock, par value $0.01 per share   AMN   NYSE Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).   Emerging growth company ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐             Item 2.02. Results of Operations and Financial Condition. On February 15, 2024, AMN Healthcare Services, Inc. reported its results for the fiscal quarter and year ended December 31, 2023. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated by reference herein.   The information in this Item 2.02, including Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act